Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection

Brucellosis is a zoonotic disease in human and animals. Brucella melitensis is one of the most pathogenic species of Brucella in goat and sheep. Omp31 is an outer membrane protein of Brucella that acts as an immunogenic protein. Cytokines are glycoproteins with low molecular weight that play the rol...

Full description

Bibliographic Details
Main Authors: M. Naghavi, M. H. Sekhavati, M. Tahmoorespur, M. R. Nassiri
Format: Article
Language:English
Published: Razi Vaccine and Serum Research Institute 2018-09-01
Series:Archives of Razi Institute
Subjects:
Online Access:http://archrazi.areeo.ac.ir/article_116404_4286f2e4b17f23e95d54e0bb1644ae65.pdf
_version_ 1818156209274880000
author M. Naghavi
M. H. Sekhavati
M. Tahmoorespur
M. R. Nassiri
author_facet M. Naghavi
M. H. Sekhavati
M. Tahmoorespur
M. R. Nassiri
author_sort M. Naghavi
collection DOAJ
description Brucellosis is a zoonotic disease in human and animals. Brucella melitensis is one of the most pathogenic species of Brucella in goat and sheep. Omp31 is an outer membrane protein of Brucella that acts as an immunogenic protein. Cytokines are glycoproteins with low molecular weight that play the role of an immune adjuvant and regulate immune responses. Interleukin-2 is one of the most important cytokines, which are secreted by the white blood cells and involved in T cell immune responses. In the present study, a chimeric Omp31-Interleukin2 recombinant protein was generated by means of genetic engineering techniques. This chimeric coding sequence was amplified by using specific primers and using Splicing Overlap Extension (SOE) PCR technique. The fusion of the two mentioned proteins was accomplished using a rigid linker. The generated chimeric IL2-Omp31 fragment was TA cloned, and then subcloned into pEt22b vector as an expression vector. The chimeric protein was successfully expressed in E. coli BL21 (DE3) and confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and also Western-blotting analysis. Finally, in order to assess the antigenic features of the recombinant chimeric IL2-Opm31 protein, its secondary structure and antigenicity were predicted in silico.
first_indexed 2024-12-11T14:54:39Z
format Article
id doaj.art-a78ae19380b84f30a70079876dcd24ee
institution Directory Open Access Journal
issn 0365-3439
2008-9872
language English
last_indexed 2024-12-11T14:54:39Z
publishDate 2018-09-01
publisher Razi Vaccine and Serum Research Institute
record_format Article
series Archives of Razi Institute
spelling doaj.art-a78ae19380b84f30a70079876dcd24ee2022-12-22T01:01:20ZengRazi Vaccine and Serum Research InstituteArchives of Razi Institute0365-34392008-98722018-09-0173319920610.22092/ari.2017.110504.1131116404Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella InfectionM. Naghavi0M. H. Sekhavati1M. Tahmoorespur2M. R. Nassiri3Department of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranDepartment of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranDepartment of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranDepartment of Animal Science, Faculty of Agriculture, Ferdowsi University of Mashhad, Mashhad, IranBrucellosis is a zoonotic disease in human and animals. Brucella melitensis is one of the most pathogenic species of Brucella in goat and sheep. Omp31 is an outer membrane protein of Brucella that acts as an immunogenic protein. Cytokines are glycoproteins with low molecular weight that play the role of an immune adjuvant and regulate immune responses. Interleukin-2 is one of the most important cytokines, which are secreted by the white blood cells and involved in T cell immune responses. In the present study, a chimeric Omp31-Interleukin2 recombinant protein was generated by means of genetic engineering techniques. This chimeric coding sequence was amplified by using specific primers and using Splicing Overlap Extension (SOE) PCR technique. The fusion of the two mentioned proteins was accomplished using a rigid linker. The generated chimeric IL2-Omp31 fragment was TA cloned, and then subcloned into pEt22b vector as an expression vector. The chimeric protein was successfully expressed in E. coli BL21 (DE3) and confirmed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and also Western-blotting analysis. Finally, in order to assess the antigenic features of the recombinant chimeric IL2-Opm31 protein, its secondary structure and antigenicity were predicted in silico.http://archrazi.areeo.ac.ir/article_116404_4286f2e4b17f23e95d54e0bb1644ae65.pdfBrucella melitensisInterleukinOmp31Cytokines
spellingShingle M. Naghavi
M. H. Sekhavati
M. Tahmoorespur
M. R. Nassiri
Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection
Archives of Razi Institute
Brucella melitensis
Interleukin
Omp31
Cytokines
title Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection
title_full Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection
title_fullStr Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection
title_full_unstemmed Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection
title_short Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection
title_sort design and production of a novel recombinant chimeric il2 omp31 antigen against brucella infection
topic Brucella melitensis
Interleukin
Omp31
Cytokines
url http://archrazi.areeo.ac.ir/article_116404_4286f2e4b17f23e95d54e0bb1644ae65.pdf
work_keys_str_mv AT mnaghavi designandproductionofanovelrecombinantchimericil2omp31antigenagainstbrucellainfection
AT mhsekhavati designandproductionofanovelrecombinantchimericil2omp31antigenagainstbrucellainfection
AT mtahmoorespur designandproductionofanovelrecombinantchimericil2omp31antigenagainstbrucellainfection
AT mrnassiri designandproductionofanovelrecombinantchimericil2omp31antigenagainstbrucellainfection